Cancer Policy Science advocates organize march in DC to demand impeachment of RFK Jr. October 24, 2025Vol.51 No.39By Sara Willa Ernst
Cancer Policy Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA October 24, 2025Vol.51 No.39By Claire Marie Porter
Cancer Policy Federal official claims that temporary order blocking RIFs doesn’t apply to HHS October 24, 2025Vol.51 No.39By Sara Willa Ernst
Cancer Policy Insurance premiums set to skyrocket if Congress doesn’t reach a deal October 24, 2025Vol.51 No.39By Claire Marie Porter
Cancer Policy Trump cuts IVF drug deal with Merck in exchange for tariff exemption October 24, 2025Vol.51 No.39By Claire Marie Porter
In Brief Korman, Regev, and Rathmell awarded Cancer Research Institute honors in cancer immunotherapy October 24, 2025Vol.51 No.39
Clinical Roundup Zanzalintinib + atezolizumab improve survival in advanced CRC October 24, 2025Vol.51 No.39
Clinical Roundup Trodelvy reduces risk of disease progression or death by 38% vs. chemo as first-line therapy in metastatic TNBC October 24, 2025Vol.51 No.39
Clinical Roundup Enhertu reduced the risk of disease recurrence or death vs. T-DM1 in high-risk HER2+ early breast cancer following neoadjuvant therapy October 24, 2025Vol.51 No.39
